Response to "Nutritional considerations with antiobesity medications"

被引:0
|
作者
Athinarayanan, Shaminie J. [1 ]
机构
[1] Virta Hlth, 3513 Brighton Blvd, Denver, CO 80216 USA
关键词
D O I
10.1002/oby.24187
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:7 / 8
页数:2
相关论文
共 50 条
  • [41] Early- and later-stage persistence with antiobesity medications: A retrospective cohort study
    Gasoyan, Hamlet
    Pfoh, Elizabeth R.
    Schulte, Rebecca
    Le, Phuc
    Rothberg, Michael B.
    OBESITY, 2024, 32 (03) : 486 - 493
  • [42] Should the Same Safety Scrutiny of Antiobesity Medications be Applied to Other Chronic Usage Drugs?
    Halpern, Bruno
    Mancini, Marcio C.
    OBESITY, 2020, 28 (07) : 1171 - 1172
  • [43] Lifestyle Intervention Requirements for Novel Antiobesity Medications-Necessary Adjunct or Harmful Gatekeeper?
    Golovaty, Ilya
    Hagan, Scott
    JAMA INTERNAL MEDICINE, 2025, 185 (03) : 255 - 256
  • [44] Cardiovascular Considerations for Stimulant Class Medications
    Hammerness, Paul
    Berger, Amy
    Angelini, Michael C.
    Wilens, Timothy E.
    CHILD AND ADOLESCENT PSYCHIATRIC CLINICS OF NORTH AMERICA, 2022, 31 (03) : 437 - 448
  • [45] Pharmacogenomic considerations for medications in the perioperative setting
    Jhun, Ellie H.
    Apfelbaum, Jeffrey L.
    Dickerson, David M.
    Shahul, Sajid
    Knoebel, Randall
    Danahey, Keith
    Ratain, Mark J.
    O'Donnell, Peter H.
    PHARMACOGENOMICS, 2019, 20 (11) : 813 - 827
  • [46] Comment on: Preoperative and early adjuvant antiobesity medications in bariatric surgery patients with body mass index over 60 or suboptimal initial response to surgery
    Horn, Deborah Bade
    SURGERY FOR OBESITY AND RELATED DISEASES, 2023, 19 (08) : 841 - 842
  • [47] Can we predict treatment response to antiobesity medication?
    Susan Z Yanovski
    Nature Clinical Practice Endocrinology & Metabolism, 2006, 2 : 314 - 315
  • [48] An Efficient Approach to Expand Equitable Access to Antiobesity Medications: Deprescribing After Weight Loss Plateau
    Kim, David D.
    Fendrick, A. Mark
    AMERICAN JOURNAL OF MANAGED CARE, 2024, 30 (08): : 348 - 350
  • [49] Antiobesity Medications in Patients With Heart Failure A Clinical Protocol and Preliminary Single-Center Experience
    Hussani, Sureya F.
    Nguyen, Kelly
    Yu, Ka man
    Sinha, Darius
    Vest, Amanda R.
    JACC-HEART FAILURE, 2024, 13 (02) : 375 - 380
  • [50] Selection of Antiobesity Medications Based on Phenotypes Enhances Weight Loss: A Pragmatic Trial in an Obesity Clinic
    Acosta, Andres
    Camilleri, Michael
    Abu Dayyeh, Barham
    Calderon, Gerardo
    Gonzalez, Daniel
    McRae, Alison
    Rossini, William
    Singh, Sneha
    Burton, Duane
    Clark, Matthew M.
    OBESITY, 2021, 29 (04) : 662 - 671